224 related articles for article (PubMed ID: 17616539)
21. Time course proteomic profiling of human myocardial infarction plasma samples: an approach to new biomarker discovery.
Silbiger VN; Luchessi AD; Hirata RD; Neto LG; Pastorelli CP; Ueda EK; dos Santos ES; Pereira MP; Ramos R; Sampaio MF; Armaganijan D; Paik SH; Murata Y; Ooi GT; Ferguson EW; Hirata MH
Clin Chim Acta; 2011 May; 412(11-12):1086-93. PubMed ID: 21356205
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: multi-institution correlation of spectra and identification of biomarkers.
Rai AJ; Stemmer PM; Zhang Z; Adam BL; Morgan WT; Caffrey RE; Podust VN; Patel M; Lim LY; Shipulina NV; Chan DW; Semmes OJ; Leung HC
Proteomics; 2005 Aug; 5(13):3467-74. PubMed ID: 16052624
[TBL] [Abstract][Full Text] [Related]
23. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
24. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
25. Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.
Xu W; Hu Y; Li J; He X; Fu Z; Pan T; Liu H; He H; Ge W; Yu J; Wei Q; Zheng S; Chen Y; Zhang S
Discov Med; 2015 Oct; 20(110):239-53. PubMed ID: 26562477
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a novel, integrated approach using functionalized magnetic beads, bench-top MALDI-TOF-MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma.
Zhang X; Leung SM; Morris CR; Shigenaga MK
J Biomol Tech; 2004 Sep; 15(3):167-75. PubMed ID: 15331582
[TBL] [Abstract][Full Text] [Related]
27. Urine profiling by SELDI-TOF/MS: monitoring of the critical steps in sample collection, handling and analysis.
Papale M; Pedicillo MC; Thatcher BJ; Di Paolo S; Lo Muzio L; Bufo P; Rocchetti MT; Centra M; Ranieri E; Gesualdo L
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):205-13. PubMed ID: 17613287
[TBL] [Abstract][Full Text] [Related]
28. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
[TBL] [Abstract][Full Text] [Related]
29. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
30. New serum biomarkers for detection of tuberculosis using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Liu JY; Jin L; Zhao MY; Zhang X; Liu CB; Zhang YX; Li FJ; Zhou JM; Wang HJ; Li JC
Clin Chem Lab Med; 2011 Oct; 49(10):1727-33. PubMed ID: 21671803
[TBL] [Abstract][Full Text] [Related]
31. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
32. [Screening of potential proteins from patients with idiopathic pulmonary fibrosis by using of surface enhanced laser desorption/ionization time of flight mass spectrum].
Wei LQ; Li XR; Liu B; Peng SC
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Jul; 24(7):427-30. PubMed ID: 22748461
[TBL] [Abstract][Full Text] [Related]
33. [Application of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen biomarkers for early diagnosis of lung adenocarcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Yu JK; Zheng S
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 40(1):157-61. PubMed ID: 19292069
[TBL] [Abstract][Full Text] [Related]
34. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in hypertensive and normotensive patients with coronary artery disease.
Malyszko J; Bachorzewska-Gajewska H; Malyszko JS; Pawlak K; Dobrzycki S
Nephrology (Carlton); 2008 Apr; 13(2):153-6. PubMed ID: 18275504
[TBL] [Abstract][Full Text] [Related]
35. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
36. Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.
Seibert V; Ebert MP; Buschmann T
Brief Funct Genomic Proteomic; 2005 May; 4(1):16-26. PubMed ID: 15975261
[TBL] [Abstract][Full Text] [Related]
37. Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease.
Nabity MB; Lees GE; Dangott LJ; Cianciolo R; Suchodolski JS; Steiner JM
Vet Clin Pathol; 2011 Jun; 40(2):222-36. PubMed ID: 21446987
[TBL] [Abstract][Full Text] [Related]
38. Molecular classification of liver cirrhosis in a rat model by proteomics and bioinformatics.
Xu XQ; Leow CK; Lu X; Zhang X; Liu JS; Wong WH; Asperger A; Deininger S; Eastwood Leung HC
Proteomics; 2004 Oct; 4(10):3235-45. PubMed ID: 15378689
[TBL] [Abstract][Full Text] [Related]
39. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
Cheng L; Zhou L; Tao L; Zhang M; Cui JF; Liu YK
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2526-30. PubMed ID: 18067823
[TBL] [Abstract][Full Text] [Related]
40. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
Geng X; Wang F; Li YG; Zhu GP; Zhang WM
J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
